This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Aug 20;34(24):2941-2.

doi: 10.1200/JCO.2016.67.4358. Epub 2016 May 2.

Reply to D. Vordermark and T. Pelz and R. Mazzola et al

Frederika A van Nimwegen¹, David J Cutter², Michael Schaapveld¹, Sarah C Darby², Berthe M P Aleman¹, Flora E van Leeuwen³

Affiliations

Affiliations

¹ The Netherlands Cancer Institute, Amsterdam, Netherlands.
² University of Oxford, Oxford, United Kingdom.
³ The Netherlands Cancer Institute, Amsterdam, Netherlands f.v.leewen@nki.nl.

PMID: 27138579
DOI: 10.1200/JCO.2016.67.4358

Comment

Reply to D. Vordermark and T. Pelz and R. Mazzola et al

Frederika A van Nimwegen et al. J Clin Oncol. 2016.

. 2016 Aug 20;34(24):2941-2.

doi: 10.1200/JCO.2016.67.4358. Epub 2016 May 2.

Authors

Frederika A van Nimwegen¹, David J Cutter², Michael Schaapveld¹, Sarah C Darby², Berthe M P Aleman¹, Flora E van Leeuwen³

Affiliations

¹ The Netherlands Cancer Institute, Amsterdam, Netherlands.
² University of Oxford, Oxford, United Kingdom.
³ The Netherlands Cancer Institute, Amsterdam, Netherlands f.v.leewen@nki.nl.

PMID: 27138579
DOI: 10.1200/JCO.2016.67.4358

No abstract available

PubMed Disclaimer

Comment on

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.
van Nimwegen FA, Schaapveld M, Cutter DJ, Janus CP, Krol AD, Hauptmann M, Kooijman K, Roesink J, van der Maazen R, Darby SC, Aleman BM, van Leeuwen FE. van Nimwegen FA, et al. J Clin Oncol. 2016 Jan 20;34(3):235-43. doi: 10.1200/JCO.2015.63.4444. Epub 2015 Nov 16. J Clin Oncol. 2016. PMID: 26573075
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.
Mazzola R, Giaj Levra N, Alongi F. Mazzola R, et al. J Clin Oncol. 2016 Aug 20;34(24):2940-1. doi: 10.1200/JCO.2016.66.7840. Epub 2016 May 2. J Clin Oncol. 2016. PMID: 27138576 No abstract available.
Coronary Heart Disease After Mediastinal Radiotherapy for Hodgkin Lymphoma: Can Risk Calculations From Historic Cohorts Be Used Today?
Vordermark D, Pelz T. Vordermark D, et al. J Clin Oncol. 2016 Aug 20;34(24):2939-40. doi: 10.1200/JCO.2015.65.8286. Epub 2016 May 2. J Clin Oncol. 2016. PMID: 27138580 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information